Axsome Therapeutics' Debt - II Round

Axsome Therapeutics raised a round of funding on October 30, 2013.

Axsome Therapeutics is a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders. By focusing on this therape…

Articles about Axsome Therapeutics' Debt - II Round: